TL;DR: Relu, a Belgium-based dental AI company, has received CE approval for its AI-powered implant planning software, making it the first fully automated implant design tool cleared for clinical use in the European market. The technology uses deep learning to generate surgical implant plans in seconds, reducing planning time and potentially improving predictability for complex cases. As of May 2026, the software is available to clinicians across the EU and is expected to seek regulatory clearance in other markets, including Canada.
The intersection of artificial intelligence and dental implantology just crossed a significant regulatory threshold. Relu, a dental technology company headquartered in Belgium, announced that its AI-driven implant planning software has earned CE (Conformité Européenne) approval — a milestone that positions the tool as the first of its kind cleared for clinical use in Europe.
What Does the Relu AI Software Actually Do?
Traditional implant planning requires clinicians to manually interpret CBCT scans, identify anatomical landmarks, assess bone density and volume, and position virtual implants within planning software. Even experienced clinicians spend considerable time on this process, and the results can vary based on individual skill and familiarity with the software.
Relu's AI automates much of this workflow. The software ingests CBCT data and uses a deep learning algorithm trained on thousands of implant cases to automatically segment anatomy, identify the nerve canal, map bone contours, and propose implant positions optimized for prosthetic outcomes. The clinician reviews, adjusts if needed, and approves the plan — but the heavy computational lifting is handled by the algorithm.
According to Relu, the AI generates a complete implant plan in under 60 seconds, compared to the 20 to 45 minutes a clinician might spend on manual planning.
Why CE Approval Matters for the Industry
CE marking is the European Union's conformity assessment for medical devices. Earning it means Relu's software has met the essential requirements of the EU Medical Device Regulation (MDR), including clinical evaluation, risk management, and quality system audits. This is not a rubber stamp — the MDR pathway is rigorous, particularly for AI-based software classified as a medical device.
For dental professionals, this regulatory clearance carries two practical implications. First, it validates the clinical safety and performance data behind the algorithm. Second, it opens the door for integration into guided surgery workflows at practices across the European Economic Area.
What This Means for Canadian Dentists
As of May 2026, Relu's software is not yet cleared by Health Canada. However, the CE approval signals that regulatory submissions in other markets, including Canada, are likely on the horizon. Canadian dentists who already use guided implant surgery should monitor this space closely — AI-assisted planning could meaningfully reduce chair time and improve case predictability, particularly for full-arch reconstructions and cases with compromised bone.
Health Canada's regulatory framework for Software as a Medical Device (SaMD) has been evolving alongside international standards. The Royal College of Dental Surgeons of Ontario (RCDSO) has noted that AI tools used in clinical decision-making fall under existing standards of practice, meaning the dentist remains responsible for treatment decisions regardless of algorithmic assistance.
The Broader AI Trend in Implant Dentistry
Relu is not operating in isolation. Several companies are pursuing AI-powered implant planning, including 3Shape, which unveiled advanced AI lab workflows earlier this year, and Overjet, which continues to expand its diagnostic AI platform. The convergence of CBCT imaging, AI diagnostics, and digital guided surgery is creating a new standard for predictability in implant placement.
For practices in Toronto and the Greater Toronto Area, where competition for implant patients is intense, early adoption of these technologies could become a differentiator. Patients increasingly research dental providers online, and practices that can demonstrate advanced digital workflows — including AI-assisted planning — may have an edge in attracting complex restorative cases.
Pro Tip: If your practice is considering guided implant surgery, start building your digital workflow foundation now. Invest in a high-quality CBCT scanner and intraoral scanner, and train your team on digital planning software. When AI planning tools receive Health Canada clearance, you will be positioned to integrate them immediately rather than scrambling to catch up.
Clinical Implications Worth Watching
The most promising aspect of AI implant planning is not speed alone — it is consistency. Human planners, even skilled ones, introduce variability. An AI trained on thousands of successful outcomes can propose implant positions that account for prosthetic requirements, biomechanical loading, and anatomical constraints simultaneously. This does not replace clinical judgment, but it provides a data-driven starting point that may reduce planning errors.
Studies published in peer-reviewed journals have demonstrated that AI-planned implant positions fall within clinically acceptable deviations compared to expert-planned cases. The key question going forward is whether AI-assisted planning translates to better long-term outcomes — peri-implant bone levels, prosthetic complications, and patient-reported satisfaction. That data will take years to accumulate, but the early signals are encouraging.
What Canadian Regulatory Bodies Are Saying
The Canadian Dental Association (CDA) has acknowledged that artificial intelligence will play an increasingly significant role in dental diagnostics and treatment planning. In its 2026 technology position statements, the CDA encouraged practitioners to stay informed about AI developments while emphasizing that these tools should augment — not replace — clinical expertise.
The Ontario Dental Association (ODA) has not issued specific guidance on AI implant planning but has indicated through its continuing education programming at ASM26 that digital workflows, including AI integration, are a priority topic for the profession.
Frequently Asked Questions
Q: Is AI implant planning software available for use in Canadian dental practices?
As of May 2026, no AI-specific implant planning software has received Health Canada clearance. However, several products, including Relu's CE-approved software, are expected to pursue regulatory approval in Canada. Canadian dentists should monitor Health Canada's Medical Devices Active Licence Listing for updates.
Q: Does AI implant planning replace the need for a skilled implant dentist?
No. AI planning tools propose implant positions based on algorithmic analysis of imaging data, but the treating dentist is responsible for reviewing, modifying, and approving all treatment plans. The RCDSO standard of practice requires that the dentist exercise independent professional judgment regardless of the technology used.
Q: How much does AI implant planning software cost?
Pricing varies by vendor and licensing model. Most AI planning platforms use a subscription or per-case fee structure. As these tools enter the Canadian market, expect pricing to range from $200 to $500 CAD per case, or $5,000 to $15,000 CAD annually for unlimited use, depending on volume.
EBIKO Dental will continue monitoring AI developments in dental implantology and will provide updates as these technologies become available to Canadian practices. For the latest dental industry news and clinical insights, visit ebiko.ca.